Načítá se...
Clinical potential of gene mutations in lung cancer
Lung cancer is the most common cancer type worldwide and the leading cause of cancer related deaths in the United States. The majority of newly diagnosed patients present with late stage metastatic lung cancer that is inoperable and resistant to therapies. High-throughput genomic technologies have m...
Uloženo v:
| Vydáno v: | Clin Transl Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4658345/ https://ncbi.nlm.nih.gov/pubmed/26603430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-015-0074-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|